Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system's coordinators, helping other immune cells fight longer and harder.
A team of researchers has identified a number of uncommon helper T cell subtypes that are linked to immune conditions like asthma, rheumatoid arthritis, and multiple sclerosis.
The human immunodeficiency virus type 1 (HIV) inserts a copy of its DNA into human immune cells as a component of its life cycle. HIV latency is the term used to describe the long-lasting inert, latent condition that some of these newly infected immune cells might enter.